MIRA INFORM REPORT

 

 

Report No. :

303701

Report Date :

30.01.2015

 

IDENTIFICATION DETAILS

 

Name :

PHIL INTER PHARMA CO LTD (1)

 

 

Registered Office :

25 St 8 Vietnam - Singapore Industrial Park, Thuan An Dist, Binh Duong

 

 

Country :

Vietnam

 

 

Financials (as on) :

2013

 

 

Date of Incorporation :

23.09.2009

 

 

Legal Form :

Private Company With Limited Liability

 

 

Line of Business :

Manufacturer of Medical Equipment & Pharmaceuticals.

 

 

No. of Employee :

290

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

Vietnam

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

VIETNAM - ECONOMIC OVERVIEW

 

Vietnam is a densely-populated developing country that has been transitioning from the rigidities of a centrally-planned economy since 1986. Vietnamese authorities have reaffirmed their commitment to economic modernization in recent years. Vietnam joined the World Trade Organization in January 2007, which has promoted more competitive, export-driven industries. Vietnam became an official negotiating partner in the Trans-Pacific Partnership trade agreement in 2010. Agriculture's share of economic output has continued to shrink from about 25% in 2000 to less than 20% in 2013, while industry's share increased from 36% to more than 42% in the same period. State-owned enterprises account for about 40% of GDP. Poverty has declined significantly, and Vietnam is working to create jobs to meet the challenge of a labor force that is growing by more than one million people every year. The global recession hurt Vietnam's export-oriented economy, with GDP in 2013 growing at 5%, the slowest rate of growth since 1999. In 2013, however, exports increased by more than 12%, year-on-year; several administrative actions brought the trade deficit back into balance. Between 2008 and 2011, Vietnam's managed currency, the dong, was devalued in excess of 20%, but its value remained relatively stable in 2013. Hanoi has oscillated between promoting growth and emphasizing macroeconomic stability in recent years. In February 2011, the government shifted from policies aimed at achieving a high rate of economic growth, which had stoked inflation, to those aimed at stabilizing the economy, through tighter monetary and fiscal control. Although Vietnam unveiled a broad, "three pillar" economic reform program in early 2012, proposing the restructuring of public investment, state-owned enterprises, and the banking sector, little perceptible progress has been made. Vietnam's economy continues to face challenges from an undercapitalized banking sector. Non-performing loans weigh heavily on banks and businesses.

 

Source : CIA

 

 


REGISTERED NAME & COMPANY SUMMARY

 

Company Details

Organization Name

:

PHIL INTER PHARMA CO LTD (1)

Address

:

25 St 8 Vietnam - Singapore Industrial Park, Thuan An Dist, Binh Duong

Country

:

Vietnam

Phone (S)

:

[+84] 650-3767040

Facsimile

:

[+84] 650-3767039

Email

:

info@phil.vn

Website

:

http://www.phil.vn

Primary Business Activity

:

Manufacturer

Key Industry

:

Medical Equipment & Pharmaceutical

 

Key Facts

 

Registered Legal Address

:

25 St 8 Vietnam - Singapore Industrial Park, Thuan An Dist, Binh Duong

 

Operational Address

:

25 St 8 Vietnam - Singapore Industrial Park, Thuan An Dist, Binh Duong

 

Issuing Authority

:

Dept. of Planning & Investment - Binh Duong

 

License Number

:

463023000233

 

License Status

:

License exists - Normal.

 

Legal Form - Category

:

Private Company with Limited Liability

 

Legal Form

:

Company Limited

 

Legal Form - Abbreviation

:

CO LTD

 

Operational Status of Business

:

Normal

 

Date of Registration

:

23 Sep, 2009

 

Employees

:

290

 

Capital

:

US$ 10,000,000

 

Note

:

(1) Legal status of the English corporate name
The English name of the Subject Business Entity (SBE) is a randomly selected translation / transliteration made by the owners of the SBE. It is not a registered English corporate name, but simply a translation / transliteration of the local language name.

 

 

 

 

 

 

Report Details

 

 

Country

:

Vietnam

Business Entity Name

:

PHIL INTER PHARMA CO LTD

Primary Business Activity

:

Manufacturer

Primary Industry

:

Medical Equipment & Pharmaceutical

Office Contact Details

Operating Address

:

25 St 8 Vietnam - Singapore Industrial Park, Thuan An Dist, Binh Duong

Tel

:

[+84] 650-3767040

 

:

[+84] 650-3766170

 

:

[+84] 650-3767044

Fax

:

[+84] 650-3767039

Email

:

info@phil.vn

Website Details

Website

:

http://www.phil.vn

Status

:

Normal - operational

Country of Registration

:

Vietnam

Tax / VAT Details

Tax Issuing Authority

:

Ministry of Finance

Local Name Used

:

Gia Trj Gia Tang (Value Added Tax)

Acronym

:

GTGT / VAT

GTGT / VAT Number

:

3700621583

Date of Issuance

:

3 Aug, 2005

 

 

 

DIRECTORS/MANAGEMENT

 

Key Person

Legal Title

:

Managing Director

Name

:

Mr. Oh-Hong Soon

Nationality

:

Korean

 

 

COMPANY MANAGEMENT

 

 

 

Management Listings

 

 

Name

Nationality

Job Description

Dept. / Division

1

Mr. Young-Jung Kim

Korean

Deputy Managing Director

-

2

Ms. Nguyen Thi Thai

Vietnamese

Chief Accountant

-

 

 

Management Details - 1

Personal Unique Identifier

:

MI03815140

Name

:

Mr. Young-Jung Kim

 

 

 

Management Details - 2

Personal Unique Identifier

:

MI03815141

Name

:

Ms. Nguyen Thi Thai

 

Date of Birth

:

1976

 

COMPANY DIRECTORS

 

1

 

 

Personal Unique Identifier

:

MI03815134

Name

:

Mr. Oh-Hong Soon

Date of Birth

:

1964

 

 

NEGATIVE INFORMATION

 

 

REPUTATION

 

Reference checking for the purpose of establishing PHIL INTER PHARMA CO LTD's reputation within the respective industry failed to reveal any adverse information.

 

 

NEGA-SCAN - ADVERSE DATA MONITORING

 

 

DISHONORED CHECKS

 

No Record Found

 

 

DEBT

 

No Record Found

 

 

CIVIL LITIGATION

 

No Record Found

 

 

PERFORMANCE DEFAULTS

 

No Record Found

 

 

ADVERSE LOCAL MEDIA COVERAGE / ADVERSE FILING HISTORY

 

No Record Found

 

 

 

 

SHARE & SHARE CAPITAL INFORMATION

 

 

CAPITAL (Currency: USD - US Dollar)

 

Authorized Capital

:

$ 10,000,000

 

 

SHAREHOLDERS

 

 

Total number of shareholders

:

n/a

Total number of shares

:

n/a

 

Currency

:

USD - US Dollar

 

No.

Shareholders

Country

Shares

Number

Amount (USD)

%

1

PHIL INTERNATIONAL CO LTD

Korea, South (Republic of Korea)

n/a

n/a

50.00

2

Undisclosed Shareholders

n/a

n/a

n/a

12.73

3

Mr. Hyuk-Lee Soon

Korea, South (Republic of Korea)

n/a

n/a

10.00

4

Mr. Sook-Lee Nam

Korea, South (Republic of Korea)

n/a

n/a

7.50

5

Mr. Il-Hwang Young

Korea, South (Republic of Korea)

n/a

n/a

5.00

6

Mr. Jung-Kim Hee

Korea, South (Republic of Korea)

n/a

n/a

5.00

7

Mr. Sook-Yoon Jin

Korea, South (Republic of Korea)

n/a

n/a

5.00

8

Mr. Sang-Chang Gyu

Korea, South (Republic of Korea)

n/a

n/a

4.77

Total

n/a

n/a

100.00

 

Based on corporate statutory laws / regulations in Vietnam, there is no requirement for public disclosure of Shareholders. In this case, the Shareholders information was supplied by the Subject Business Entity.
However in the absence of data normally obtained from local Statutory Authorities, it is not possible to verify the accuracy of data supplied and hence is provided as reference ONLY.

 

PAYMENT INFORMATION

 

 

PAYMENT TERMS

 

Selling

 

Type

Terms

Local

Cash on delivery (COD)

Credit - Secured with Post-dated checks 30~60 days

Export

Letter of Credit (At-sight)

Telegraphic Transfer (T/T) - Received at time of transaction

 

Purchasing

 

Type

Terms

Local

Cash on delivery (COD)

Credit - Secured with Post-dated checks 30~60 days

Import

Letter of Credit (At-sight)

Telegraphic Transfer (T/T) - Executed at time of transaction

 

 

GROUP STRUCTURE & AFFILIATED COMPANIES

 

Na

 

 

FINANCIAL INFORMATION

 

Financials - Summary  (Currency: USD - US Dollar)

Year

Sales

Assets

Net Income

2011 Annual  

13,960,490

17,573,116

528,469

2012 Annual  

17,318,890

20,243,788

1,022,682

2013 Annual (*)

19,825,598

19,829,297

1,650,315

 

Sales Trend – Analysis

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

-

-

-

-

-

-

-

-

Note: (*)

Financials listed are the most recent available for this company.

 

 

FINANCIAL STATEMENT - DETAILED

 

Balance Sheet

 

Currency

:

VND

Denomination

:

1

Financial Year Ending

:

December

 

Financial Highlights

2011 Annual

2012 Annual

2013 Annual

Current Assets(*)

134,799,000,000

153,090,000,000

167,076,000,000

Non Current Assets(*)

231,249,000,000

268,480,000,000

251,086,000,000

Non Current Liabilities(*)

14,355,000,000

22,386,000,000

14,555,000,000

Share Capital(*)

165,403,000,000

165,403,000,000

165,403,000,000

Other long term assets 

Total Assets(*)

366,048,000,000

421,570,000,000

418,162,000,000

Total Liabilities(*)

145,567,000,000

186,731,000,000

155,532,000,000

Current Liabilities(*)

131,212,000,000

164,345,000,000

140,977,000,000

Long term liabilities 

Shareholders Funds(*)

220,481,000,000

234,839,000,000

262,630,000,000

 

Current assets & short term investments

134,799,000,000

153,090,000,000

167,076,000,000

Cash & cash equivalents

2,460,000,000

11,838,000,000

15,525,000,000

Cash

2,460,000,000

11,838,000,000

12,525,000,000

Cash equivalents

-

-

3,000,000,000

Accounts receivable

41,432,000,000

48,700,000,000

68,377,000,000

Accounts receivable trade

36,344,000,000

47,513,000,000

64,811,000,000

Trade prepayment

2,662,000,000

531,000,000

637,000,000

Others receivables

2,426,000,000

656,000,000

2,929,000,000

Inventories

77,494,000,000

74,868,000,000

70,887,000,000

i. Inventories

77,494,000,000

74,868,000,000

70,887,000,000

Other short term asset

13,413,000,000

17,684,000,000

12,287,000,000

Prepaid expenses

1,598,000,000

598,000,000

494,000,000

VAT deductible

4,003,000,000

6,504,000,000

2,142,000,000

Other tax receivables

1,571,000,000

812,000,000

242,000,000

i. Other short term asset

6,241,000,000

9,770,000,000

9,409,000,000

Long term assets

231,249,000,000

268,480,000,000

251,086,000,000

Fixed assets

227,761,000,000

266,167,000,000

248,611,000,000

Tangible fixed assets

203,046,000,000

187,081,000,000

235,976,000,000

Cost

261,151,000,000

268,343,000,000

340,805,000,000

Accumulated depreciation

58,105,000,000

81,262,000,000

104,829,000,000

Intangible fixed assets

13,226,000,000

12,842,000,000

12,635,000,000

i. Cost

14,294,000,000

14,294,000,000

14,527,000,000

i. Accumulated depreciation

1,068,000,000

1,452,000,000

1,892,000,000

Construction in progress

11,489,000,000

66,244,000,000

-

Other long term assets

3,488,000,000

2,313,000,000

2,475,000,000

Long term prepayments

2,713,000,000

1,537,000,000

1,530,000,000

i. Other long term assets

775,000,000

776,000,000

945,000,000

Total assets

366,048,000,000

421,570,000,000

418,162,000,000

Liabilities

145,567,000,000

186,731,000,000

155,532,000,000

Current liabilities

131,212,000,000

164,345,000,000

140,977,000,000

Short term borrowings

103,014,000,000

144,666,000,000

116,200,000,000

Accounts payables-trade

17,294,000,000

8,048,000,000

9,396,000,000

Advances from customers

9,031,000,000

8,119,000,000

11,749,000,000

Taxes and payable to state budget

153,000,000

315,000,000

78,000,000

Payable to employees

958,000,000

1,190,000,000

1,225,000,000

Accrued expenses payable

661,000,000

992,000,000

1,219,000,000

Other payables

101,000,000

56,000,000

151,000,000

Long term liabilities

14,355,000,000

22,386,000,000

14,555,000,000

Long term other payables

-

47,000,000

-

Long term borrowings

14,288,000,000

22,339,000,000

14,555,000,000

Provision funds for unemployment

67,000,000

-

-

Owner's equity

220,481,000,000

234,839,000,000

262,630,000,000

i. Owner's equity

219,522,000,000

234,839,000,000

262,630,000,000

Business capital

165,403,000,000

165,403,000,000

165,403,000,000

Business development funds

4,296,000,000

4,296,000,000

4,296,000,000

Other funds from owner's equity

114,000,000

113,000,000

114,000,000

Retained earnings

49,709,000,000

65,027,000,000

92,817,000,000

Budget sources

959,000,000

-

-

Bonus and welfare funds

959,000,000

-

-

Total resources

366,048,000,000

421,570,000,000

418,162,000,000

 

Note: (*)

 

Financial Highlights

 

 

Income Statement

 

Currency

:

VND

Denomination

:

1

Financial Year Ending

:

December

 

Financial Highlights

2011 Annual

2012 Annual

2013 Annual

Turnover(*)

290,797,000,000

360,660,000,000

418,084,000,000

Profit (Loss) Before Tax(*)

11,727,000,000

22,742,000,000

37,832,000,000

Profit After Tax attributable to Shareholders(*)

11,008,000,000

21,297,000,000

34,802,000,000

 

Gross sales

290,797,000,000

360,660,000,000

418,084,000,000

Less deductions

57,000,000

1,718,000,000

727,000,000

Net income

290,740,000,000

358,942,000,000

417,357,000,000

Cost of goods sold

187,411,000,000

226,194,000,000

263,724,000,000

Gross margin

103,329,000,000

132,748,000,000

153,633,000,000

Income from financial activities

2,630,000,000

1,064,000,000

724,000,000

Expenses from financial activities

16,157,000,000

12,905,000,000

14,223,000,000

In which: Interest expenses

9,872,000,000

0

12,224,000,000

Selling expenses

7,425,000,000

13,565,000,000

16,812,000,000

General & administration expenses

67,190,000,000

81,574,000,000

84,007,000,000

Net income from operating activities

15,187,000,000

25,768,000,000

39,315,000,000

Extraordinary income

350,000,000

269,000,000

240,000,000

Extraordinary expenses

3,810,000,000

3,295,000,000

1,723,000,000

Extraordinary gains

(3,460,000,000)

(3,026,000,000)

(1,483,000,000)

Net profit before tax

11,727,000,000

22,742,000,000

37,832,000,000

Income tax

719,000,000

1,445,000,000

3,030,000,000

Net profit after tax

11,008,000,000

21,297,000,000

34,802,000,000

 

Note: (*)

 

Financial Highlights

 

 

Financial Ratios

 

Financial Highlights

2011 Annual

2012 Annual

2013 Annual

Growth % 

Year-on-Year Growth

-

24.02

15.92

Profitability 

Profit Margin (%)

3.79

5.91

8.32

Return on Equity (%)

4.99

9.07

13.25

Return on Assets (%)

3.01

5.05

8.32

Leverage 

Total Debt Equity (Times)

0.66

0.80

0.59

Current Debt Equity (Times)

0.60

0.70

0.54

Long Term Debt to Equity

0.07

0.10

0.06

Total Asset To Total Equity

1.66

1.80

1.59

Asset Management 

Total Assets Turnover (Times)

0.79

0.86

1.00

Fixed Assets Turnover (Times)

1.26

1.34

1.67

Liquidity 

Current Ratio

1.03

0.93

1.19

 

 

Based on the corporate laws of Vietnam, legal entities which are Private Company with Limited Liability are not required to make public disclosure of their annual financials. Although basic financials were obtained for reference.

 

 

FOREIGN EXCHANGE RATES

 

Na

 

 

ADDITIONAL INFORMATION

 

Primary Products

Products / Materials / Services Description

Activity

Pharmaceutical preparations

Manufacturing, Exporting

 

 

SIC PRODUCT CLASSIFICATION & ACTIVITY

 

 

 

Product/Service Description

Code

Activity

Pharmaceutical preparations

2834

Manufacturing, Exporting

 

 

 

 

HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY

 

 

 

Product/Service Description

Code

Activity

Pharmaceutical goods (specified sterile prod etc.)

3006

Manufacturing, Exporting

Pharmaceutical products

3000

Manufacturing, Exporting

 

 

 

 

CORE BUSINESS DESCRIPTION

 

 

 

Core Business

 

The primary business focus of PHIL INTER PHARMA CO LTD is Manufacturing - Finished products.

Key product include :

Pharmaceutical preparations

 

 

 

Supplementary Business

 

In addition to the core business, PHIL INTER PHARMA CO LTD also is engaged in the following areas of business:

Exporting

Exporting - Finished products

Importing

Importing - Raw materials

 

 

 

DOMESTIC SALES & PURCHASES

 

 

 

Annual Sales Analysis

Percentage

Domestic Sales

60%

International Sales (Export)

40%

 

 

 

 

Annual Purchases Analysis

Percentage

Local Purchases

25%

Imports

75%

 

 

 

 

BANK DETAILS

 

 

 

Bank Name

:

JOINT STOCK COMMERCIAL BANK FOR INVESTMENT & DEVELOPMENT OF VIETNAM

Global Identifier

:

32400483

Branch

:

Hoan Kiem Dist,Hanoi

Branch Address

:

JOINT STOCK COMMERCIAL BANK FOR INVESTMENT AND DEVELOPMENT OF VIETNAM - BINH DUONG, NAM

SWIFT Code

:

BIDVVNVX

 

Bank Name

:

SHINHANVINA BANK

Global Identifier

:

P0824947

Branch

:

District 1,Ho Chi Minh

Branch Address

:

SHINHANVINA BANK - BINH DUONG

SWIFT Code

:

SHBKVNVN

 

 

 

INTERNATIONAL TRADE - Activity & Markets

 

 

 

 

Country / Region

Estimated level of importance

Trading Activity

Africa

Medium

Exporting

Asia / Pacific

Medium

Importing, Exporting

China

Medium

Importing

India

Medium

Importing

Korea, South (Republic of Korea)

Medium

Importing

Myanmar

Medium

Exporting

Singapore

Medium

Exporting

South Africa

Medium

Exporting

 

 

 

 

OFFICE & FACILITIES

 

The following information relates to the Business Entity's office as listed above:

 

Name

:

PHIL INTER PHARMA CO LTD - THUAN AN DIST, BINH DUONG

Primary Use

:

Office & Administration facilities

Employees

:

290

Address

:

25 St 8 Vietnam - Singapore Industrial Park, Thuan An Dist, Binh Duong

Country

:

Vietnam

Status

:

Operational

 

 

 

 

PREVIOUS BUSINESS LICENSE/S

 

 

 

License Date

License No.

1 Jul, 2005

2388/GP

 

 

 

NOTES & COMMENTS

 

Na

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.50

UK Pound

1

Rs.93.12

Euro

1

Rs.69.33

 

 

INFORMATION DETAILS

 

Analysis Done by :

SUB

 

 

Report Prepared by :

TPT

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.